Department of Natural Products & Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Inflammopharmacology. 2024 Oct;32(5):2821-2859. doi: 10.1007/s10787-024-01562-4. Epub 2024 Aug 28.
The incidence and prevalence of inflammatory-related diseases (IRDs) are increasing worldwide. Current approved treatments for IRDs in the clinic are combat against inhibiting the pro-inflammatory cytokines. Though significant development in the treatment in the IRDs has been achieved, the severe side effects and inefficiency of currently practicing treatments are endless challenge. Drug discovery from natural sources is efficacious over a resurgence and also natural products are leading than the synthetic molecules in both clinical trials and market. The use of natural products against IRDs is a conventional therapeutic approach since it is a reservoir of unique structural chemistry, accessibility and bioactivities with reduced side effects and low toxicity. In this review, we discuss the cause of IRDs, treatment of options for IRDs and the impact and adverse effects of currently practicing clinical drugs. As well, the significant role of natural products against various IRDs, the limitations in the clinical development of natural products and thus pave the way for development of natural products as immunomodulators against IRDs are also discussed.
炎症相关疾病(IRDs)的发病率和患病率在全球范围内呈上升趋势。目前临床上针对 IRDs 的治疗方法是对抗抑制促炎细胞因子。尽管在治疗 IRDs 方面取得了重大进展,但目前治疗方法的严重副作用和低效性仍然是一个无尽的挑战。从天然来源中发现药物比合成分子更有效,而且在临床试验和市场上,天然产品也领先于合成分子。使用天然产品治疗 IRDs 是一种常规的治疗方法,因为它是一种具有独特结构化学、可及性和生物活性的宝库,副作用小,毒性低。在这篇综述中,我们讨论了 IRDs 的病因、治疗选择以及目前临床用药的影响和不良反应。此外,还讨论了天然产物在治疗各种 IRDs 中的重要作用、天然产物在临床开发中的局限性,为天然产物作为免疫调节剂治疗 IRDs 铺平了道路。